These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38705481)

  • 1. Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapies.
    Vizcaino Castro A; Daemen T; Oyarce C
    Immunol Lett; 2024 Jun; 267():106864. PubMed ID: 38705481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Antigen Presentation in Tumor-Associated Macrophages.
    Stopforth RJ; Ward ES
    Crit Rev Immunol; 2020; 40(3):205-224. PubMed ID: 33389885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
    Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
    Biomed Pharmacother; 2024 Aug; 177():116930. PubMed ID: 38878638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies.
    Dong Y; Wan Z; Gao X; Yang G; Liu L
    Front Immunol; 2021; 12():609762. PubMed ID: 33968014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.
    Toledo B; Zhu Chen L; Paniagua-Sancho M; Marchal JA; Perán M; Giovannetti E
    J Hematol Oncol; 2024 Jun; 17(1):44. PubMed ID: 38863020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor-associated macrophages to synergize tumor immunotherapy.
    Xiang X; Wang J; Lu D; Xu X
    Signal Transduct Target Ther; 2021 Feb; 6(1):75. PubMed ID: 33619259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs.
    Jung M; Bonavida B
    Crit Rev Oncog; 2024; 29(4):1-17. PubMed ID: 38989734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research trends in pharmacological modulation of tumor-associated macrophages.
    Wang N; Wang S; Wang X; Zheng Y; Yang B; Zhang J; Pan B; Gao J; Wang Z
    Clin Transl Med; 2021 Jan; 11(1):e288. PubMed ID: 33463063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Depletion of M2 Macrophages: Implication in Cancer Immunotherapy.
    Festekdjian T; Bonavida B
    Crit Rev Oncog; 2024; 29(4):55-73. PubMed ID: 38989738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment.
    Li W; Yuan Q; Li M; He X; Shen C; Luo Y; Tai Y; Li Y; Deng Z; Luo Y
    Front Immunol; 2024; 15():1452078. PubMed ID: 39144141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
    Anfray C; Ummarino A; Andón FT; Allavena P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31878087
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical landscape of macrophage-reprogramming cancer immunotherapies.
    Rannikko JH; Hollmén M
    Br J Cancer; 2024 Sep; 131(4):627-640. PubMed ID: 38831013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment.
    Pukhalskaia TV; Yurakova TR; Bogdanova DA; Demidov ON
    Biochemistry (Mosc); 2024 May; 89(5):839-852. PubMed ID: 38880645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
    Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
    Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion.
    Yu KX; Yuan WJ; Wang HZ; Li YX
    Cancer Immunol Immunother; 2024 May; 73(6):115. PubMed ID: 38693304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.